Nonetheless, VEGF serum levels may be useful to refine prognosis of patients with early CLL; higher levels of sVEGF were associated with a shorter time of DP in Binet stage A patients with either low or high β2-m levels. The gene discussed is VEGFA; the disease is B-cell chronic lymphocytic leukemia.